medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (4)

Dermal fillers in dermatology

Cheng FI, Moreno GJL

Language: Spanish
References: 70
Page: 275-285
PDF size: 153.73 Kb.


ABSTRACT

Dermal fillers are substances that are injected into the dermis. They can be classified, by their nature, as autologous, semisynthet, allograft and synthetetic. Depending on the site of application, as dermal, subdermal and periosteal. And finally, they can be classified, depending on the time they stay, as temporal and permanent.


REFERENCES

  1. Hoefflin SM. “The youthful face: tight is not right, repositioning is right”. Plas Reconstr surg 1998; 101: 1417.

  2. Hasson AN. “Rellenos e inyectables en dermatología”. Rev chilena dermatol 2008; 24: 195-196.

  3. Neuber F. “Fettransplation”. Cuit Krongr VerhGesl Chir 1893; 22: 66.

  4. Gersvny R. “Veber eine subcutgane prosthese”. Zstschr Heil Kunde 1992; 26: 1-8.

  5. Vedamurthy M. “Soft tissue augmentation-use of hyaluronic acid as dermal filler”. J Indian Dermatol Venereol Leprol 2004; 70: 383-387.

  6. Wollina U, Goldman A, Berger U, Abdel- Naser MB. “Esthetic and cosmetic Dermatology”. Dermatol Ther 2008; 21: 118-130.

  7. Vedamurthy M. “Standard guidelines for the use of dermal fillers”. J Indian Dermatol Venereol Leprol 2008; 74(Suppl1): s23-s27.

  8. Sturm LP, Cooter RD, Mutimer KL Graham JC, Maddern GJ. “A systemic review of dermal fillers for HIV-Associated facial Lipoatrophy”. AIDS Patient Care STDS 2009; 23: 699-714

  9. Pinski KS. “Soft tissue augmentation for the new millennium”. Dermatol Ther 2000; 13: 192-197.

  10. Drake L, Dinehart SM, Farmer ER, et al. “Guidelines of care for soft tissue augmentation”. Am Acad Dermatol 1996: 36: 695-607.

  11. Baumann L, Kaufman J, Saghari Sogol. “Collagen Fillers”. Dermatol Ther 2006; 19: 134-140.

  12. Castrow FF, Krull EA. “Injectable collagen implant-update”. J Am Acad Dermatol 1998; 9: 889-893.

  13. Siegel RJ, McCoy JP, Schade W, Swanson NA. “Intradermal implantion of bovine collagen. Humoral responses associated with clinical reactions”. Arc Dermatol 1984; 120: 183-187.

  14. Bauman L. “CosmoDerm/CosoPlast (human bioengineered collagen) for the aging face”. Facial Plast Surg 2004; 20: 125-128.

  15. Perret S, Eble JA, Siljander PR, et al. “Prolyhydroxylation of collagen type I is required for efficient binding to integrin alpha 1 beta and platelet glycoprotein VI but not to alpha 2 beta”. J Biol Chem 2003; 278: 29873- 29879.

  16. Okada S, Hagan JB, Kato M, et al. “Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils”. J Immunol 1998; 160: 4010-4017.

  17. Roo-Rodríguez E. “La elección del material de relleno”. Piel 2007; 22: 481-482.

  18. Matarasso SL. “Injectable collagens: lost but not forgotten—a review” of products, indications, and injection techniques. Plast Reconstr Rurg 2007; 120 (Suppl6): s17-s26.

  19. Glaich A, Cohen J, Goldberg L. “Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers”. Dermatol Surg 2006; 32: 276-281.

  20. Conejo-Mir J, Moreno JC, Camacho FM. Manual de dermatología. 1ª Ed. España, Biblioteca Aula Médica, 2010: 1363-1379.

  21. Tezel A, Fredrickson GH. “The science of hyaluronic acid dermal fillers”. J Cosmet Laser Ther 2008; 10: 35-42.

  22. Sharma P, Sharma S. “Comparative study of new dermal filler Uma Jeunesse and Juvéderm”. J Cosmet Dermatol 2011; 10: 118-125.

  23. Gold M. “The science and art of hyaluronic acid dermal filler use in esthetic applications”. J Cosmet Dermatol 2009; 8: 301-308.

  24. Born T. “Hyaluronic acids”. Clin Plast Surg 2006; 33: 525-538.

  25. Lupo Mp. “Hyaluronic acid fillers in facial rejuvenation”. Semin Cutan Med Surg 2006; 25: 122-126.

  26. Kablik J, Monheit GD, Yu L, Chang G. “Comparative Physical properties of Hyaluronic Acid Dermal fillers”. Dermato Surg 2009; 35: 302-312.

  27. Andre P. “New trends in face rejuvenation by hyaluronic acid injections”. J Cosmet Dermatol 2008; 7: 251-258.

  28. Whal G. “European evaluation of a new hyaluronic acid filler incorporating lidocaine”. J Cosmet Dermatol 2008; 7: 298-303.

  29. Raspaldo H. “Volumizing effect of a new hyaluronic acid sub-dermal facial filler: A retrospective analysis base don 102 cases”. J Cosmet Laser Ther 2008; 10: 134-142.

  30. Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, et al. “ stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin”. Arch Dermatol 2007; 143: 155-163.

  31. Baumann. « « Dermal Fillers. J Cosmet Dermatol 2004; 4: 249-250.

  32. Grimes P, Thomas JA, Murphy D. “Safety and effectivess of hyaluronic acid fillers in skin of color”. J Cosmet Dermatol 2009; 8: 162-168.

  33. Vleggaar D, Bauer U. “Facial enhancement and the European experience whit Sculptra (poly-L-lactic acid)”. J Drugs Dermatol 2004; 1: 542- 547.

  34. Athanasiou KA, Niederauer GG, Agrawal CM, Landsman AS. “Applications of biodegradable lactides and glycolides in podiatry”. Clin Podiatri Med Surg 1995; 1: 475-495.

  35. Humble G, Mest D. “Soft tissue augmentation using sculptra”. Facial Plast Surg 2004; 20: 157-163.

  36. Rotunda AM, Narins RS. “Poly-L-lactic acid: a new dimension in soft tissue augmentation”. Dermatol Ther 2006; 19: 151-158.

  37. Lowe N, Maxwell A, Rickie P. “Adverse reaction to dermal fillers: review”. Dermatol Surg 2005; 31: 1626-1633.

  38. Narins RS, Baumman L, Brandt FS, Fagien S, et al. « A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus humanbases collagen implant in the treatment of nasolabial fold wrinkles”. J Am Acad Dermatol 2010; 62: 448-462.

  39. Berlin A. Cohen JL, Goldberg DJ. “Calcium hydroxylapatitae for facial rejuvenation”. Semin Cutan Med Surg 2006; 25; 132-137.

  40. Alam M, Havey J, Pace N, Pongprutthipan M, et al. “Large-particle calcium hidroxypatite injection for correction of facial wrinkles and depressions”. J Am Acad Dermatol 2011; 65: 92-96.

  41. Alam M, Yoo SS. “Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions”. J Am Acad Dermatol 2007: 56: 285-289.

  42. Marmur E, Green L, Busso M. “Controlled, Randomized Study of Pain Levels in Subjects Treated with Calcium Hydroxylapatite premixed with lidocaine for correction of nasolabial folds”. Dermatolocis Surgery 2010; 36: 309-315.

  43. Fox LP, Geyer AS, Husain S, Della-Latta P, et al. “Mycobacterium abscessus cellulitis and multifocal abscesses of the breast in a transexual from illicit intramammary injections of silicone”. J Am Acad Dermatol 2004; 50: 450-454.

  44. Houpt K. “Autoimmune connective tissue disease and connective tissue disease-like illnesses after silicone gel augmentation mammoplasty”. J Am Acad Dermatol 1994; 31: 626-642.

  45. Hevia O. “”Liquid injectable silicone (polydimethylsiloxane): four years of clinical experience. J Am Acad Dermatol. 2007; 56 SUPPL 2: AB1.

  46. Arin MJ, Bäte J, Krieg T, Hunzelmman N. “Silicone granuloma of the face treated with minocycline”. J Am Acad Dermatol 2005; 52: (Suppl1): s53-s56.

  47. Orentreich D, Leone AS. “A case of HIV- associated facial lipoatrophy treated with 1000-cs liquid injectable silicone”. Dermatol Surg 2004; 30: 548-551.

  48. Pacini S, Ruggiero M, Morucci G, Cammarota N, Protopapa C, Gulisano M. “Bio-alcamid: a novelty for reconstructive and cosmetic surgery”. Ital J Anat Embryol 2002; 107(3): 209-214.

  49. Loutfy MR, Raboud JM, Antoniou T, Kovacs C, Shen S, Halpenny R, et al. “Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients”. AIDS 2007; 21(9): 1147-1155.

  50. Karim RB, de Lint CA, van Galen SR, van Rozelaar L, Nieuwkerk PT, Askarizadeh E, et al. “Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients”. Aesthetic Plast Surg 2008; 32(6): 873-878.

  51. Ross AH, Malhotra R. “Long-term orbitofacial complications of polyalkylimide 4% (bio-alcamid)”. Ophthal Plast Reconstr Surg 2009; 25(5): 394-397.

  52. Ocampo Candiani J, Sobrevilla Ondarza S, Velázquez Arenas L, Vázquez Martínez OT. “Complication of a polyalkylimide implant in a patient with facial trauma”. Dermatol Surg 2008; 34(9):1280-1282.

  53. Pallua N, Wolter TP. “A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients”. Plast Reconstr Surg 2010; 125(6): 1797-1804.

  54. Ono S, Ogawa R, Hyakusoku H. “Complications after polyacrylamide hydrogel injection for soft-tissue augmentation”. Plast Reconstr Surg 2010; 126(4):1349-1357.

  55. Ogden S, Griffitsh TW. “A review of minimally invasive cosmetic procedures”. Br Journal Dermat 2008; 159: 1036-1050.

  56. Narins RS. “Five years postapproval study of novel polymethylmethacrylate soft tissue filler: Year 1 interim analysis”. J Am Acad Dermatol 2009; 60 SUPPLE1: AB190.

  57. Glashofer M, Lawrance L. “Fat transplantation for treatment of the senescent face”. Dermatol Ther 2006; 19: 169-176.

  58. Berman M. “Rejuvenation of the upper eyelid complex with autologous fat transplantation”. Dermatol Surg 2000; 26: 1113-116.

  59. Guaraldi G, De fazio D, Orlando G, Murri R, et al. “Facial lipohypertrophy in HIV- infected subjects who underwent autologous fat tissue transplantation”. Clin Infect Dis 2005; 40: 13-15.

  60. Roh MR, Jung JY, Chung KY. “Autologous fat transplantation for depressed linear Pulgam S, Poulton T, Mamounas EP. “Long-Term clinical and radiologic results with autologous fat transplantation for breast augmentation: case reports and review of the literature”. Breast J 2006; 16: 63-65.

  61. Roh MR, Kim TK, Chung KY. “Treatment of infraorbital dark circles by autologous fat transplantation: a pilot study”. Br J Dermatol 2009; 160: 1022: 10025.

  62. Donofrio LM. “Structural autologous lipoaugmentation: A pan-facial technique”. Dermatol Surg 2000: 26: 1129-1134.

  63. Shiffman MA, Mirrafati S. “Fat transfer techniques: the effect of harvest and transfers methods on adipocyte viability and review of literature”. Dermatol Surg 2001; 27: 819-826.

  64. Kranendonk S, Obagi S. “Autologous fat transfer for periorbital rejuvenation: indications, technique and complications”. Dermatol Surg 2007; 33: 572-578.

  65. Mioshi K, Miyaoka T, Kobayashi Y, et al. “Hypergamma-globulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty”. Ijishimpo 1964; 2122: 9-14.

  66. Lemperle G, Morhenn V, Charrier U. “Human histology and persistence of various injectable filler substances for soft tissue augmentation”. Aesth Plast Surg 2003; 27: 354-366.

  67. Priego RB, Cárdenas RJ, Pérez R, et al. “Enfermedad humana por modelantes. Análisis de sustancias con espectrometría de resonancia magnética”. Cirugía Plástica 2010; 20 (3): 120-123.

  68. Gabriel SE, O’Fallon WM, Kurland LT, et al. “Risk of Connective-Tissue Diseases and Other Disorders after Breast Implantation”. N Engl J Med 1994; 330: 1697-1702.

  69. Lee IM, Cook NR, Shadick NA, Pereira E, Buring JE. “Prospective cohort study of breast implants and the risk of connective-tissue diseases”. Int J Epidemiol 2011; 40(1): 230-238.

  70. Khan I, Shokrollahi K, Bisarya K, Murison MS. “A liposuction technique for extraction of Bio-Alcamid and other permanent fillers”. Aesthet Surg J 2011; 31(3): 344-346.




2020     |     www.medigraphic.com